The biomedical sciences ecosystem
Following the approach set out in our launch report 'Making the UK a Global Innovation Hub', this research is looking to trace how the key actors and underpinning systems within the life sciences sector operate to either support or impede innovation. As could be expected for a study of this sector, a key focus of the work is on how academic institutions connect to and work with relevant large and small companies in the pharmaceutical arena. The next phase of the project will be to consider how well the government's new life sciences strategy delivers in this significant opportunity area.
Biomedical sciences are a key UK sector, repeatedly identified by the government as an area where the UK needs to build and capitalise on its current strengths. The innovation ecosystem is rapidly evolving with blurring of traditional roles in the supply chain. The sector's characteristics in terms of research and knowledge-generation mean that it can be viewed as a microcosm showcasing many of the broader issues that need to be addressed in improving the UK's innovation ecosystem.
- What are the key barriers to the operation of the innovation ecosystem within the biomedical and life sciences arena? What are the key levers that support this system?
- What is the impact of a rapid increase in open innovation?
- What are the gaps that could slow the innovation that the emerging technologies can deliver in this sector?